Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norifumi Takeda

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 17, 2005
[Atrial natriuretic peptide for therapy of heart failure]Norifumi Takeda
Journal of Cardiology|April 20, 2019
Genetic basis of hereditary thoracic aortic aneurysms and dissectionsNorifumi Takeda, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Efficacy and adverse reactions of atrial natriuretic peptide on kidney and cardiovascular system]Norifumi Takeda, Yasunobu Hirata
International Heart Journal|July 31, 2020
Glucose Fluctuation and Cardiovascular DiseasesTakayuki Fujiwara, Norifumi Takeda
International Journal of Inflammation|September 24, 2011
Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac RemodelingNorifumi Takeda, Ichiro Manabe
Internal Medicine (Tokyo, Japan)|September 5, 2002
Chronic advanced pulmonary hypertensionNorifumi Takeda, Kouichi Kitahara, Tetsuya Sumiyoshi
European Heart Journal|January 9, 2025
PIEZO1 as a potential therapeutic target in Marfan syndromeJin Komuro, Norifumi Takeda, Issei Komuro
Inflammation and Regeneration|December 21, 2017
Pathophysiology and therapeutic potential of cardiac fibrosisHironori Hara, Norifumi Takeda, Issei Komuro
International Heart Journal|January 24, 2017
Prostaglandin E2 Signaling as a Target of Anti-Cardiac Fibrosis in Heart Failure TreatmentMutsuo Harada, Norifumi Takeda, Haruhiro Toko
Circulation. Genomic and Precision Medicine|October 26, 2018
Response by Takeda et al to Letter Regarding Article, "Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome"Norifumi Takeda, Ryo Inuzuka, Hiroyuki Morita, et al.
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 17, 2005
[Atrial natriuretic peptide for therapy of heart failure]Norifumi Takeda
Journal of Cardiology|April 20, 2019
Genetic basis of hereditary thoracic aortic aneurysms and dissectionsNorifumi Takeda, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Efficacy and adverse reactions of atrial natriuretic peptide on kidney and cardiovascular system]Norifumi Takeda, Yasunobu Hirata
International Heart Journal|July 31, 2020
Glucose Fluctuation and Cardiovascular DiseasesTakayuki Fujiwara, Norifumi Takeda
International Journal of Inflammation|September 24, 2011
Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac RemodelingNorifumi Takeda, Ichiro Manabe
Internal Medicine (Tokyo, Japan)|September 5, 2002
Chronic advanced pulmonary hypertensionNorifumi Takeda, Kouichi Kitahara, Tetsuya Sumiyoshi
European Heart Journal|January 9, 2025
PIEZO1 as a potential therapeutic target in Marfan syndromeJin Komuro, Norifumi Takeda, Issei Komuro
Inflammation and Regeneration|December 21, 2017
Pathophysiology and therapeutic potential of cardiac fibrosisHironori Hara, Norifumi Takeda, Issei Komuro
International Heart Journal|January 24, 2017
Prostaglandin E2 Signaling as a Target of Anti-Cardiac Fibrosis in Heart Failure TreatmentMutsuo Harada, Norifumi Takeda, Haruhiro Toko
Circulation. Genomic and Precision Medicine|October 26, 2018
Response by Takeda et al to Letter Regarding Article, "Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome"Norifumi Takeda, Ryo Inuzuka, Hiroyuki Morita, et al.
Pageof 29